To study the effect of homoeopathy in cancer patients along with chemotherapy and radiotherapy
Phase 2
- Conditions
- Health Condition 1: C34- Malignant neoplasm of bronchus andlung
- Registration Number
- CTRI/2021/10/037391
- Lead Sponsor
- Department of Biotechnology DBT
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Normal hemogram, normal LFT & KFT, Blood urea 10-50mg/dl, Creatinine <1.8mg/d
Exclusion Criteria
Uncontrolled Diabetes, Pregnant and lactating patients, Patient refusing to give written consent, Deranged LFT & KFT, Confirmed cases of HIV
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To assess the improvement in QOL assess through FACT-G score <br/ ><br>To assess the loco-regional recurrence rate <br/ ><br>CTCAE grading of toxicity profileTimepoint: 2 years
- Secondary Outcome Measures
Name Time Method To corelate with genomic and molecular signaling pathwaysTimepoint: 2 years